Abbott Labs to Acquire RiverVest's IDEV Technologies for $310 Mln

Abbott Laboratories has agreed to acquire IDEV Technologies, a portfolio company of RiverVest Venture Partners. In accordance with the agreement, Abbott will acquire all outstanding equity of IDEV for $310 million. The transaction is expected to close by the end of the year. Headquartered in Webster, Texas, IDEV is a provider of medical devices.

DealsNorth AmericaUSBriefs